Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04739930 · ClinicalTrials.gov registry record · NA
Autologous Bone Marrow Concentrate in Knee Osteochondral Allograft Transplantation
A NA study of Cartilage Injury, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT04739930 is a NA study of Cartilage Injury that has completed, run by Rush University Medical Center. The registered enrollment target is 33 participants, below the 429-participant average among 4 other Cartilage Injury trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04739930, a NA study of Cartilage Injury, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to establish if mesenchymal stem cell augmentation improves graft incorporation and to analyze the cytokine environment of the joint after osteochondral allograft transplantation (OCA) with and without intra-articular bone marrow aspirate concentrate (BMAC) injection. Information learned from this study can be used to biochemically compare treatment response and to assess emerging therapeutic options that may positively alter the biochemical environment in patients who suffer from articular cartilage disorders.
Conditions Studied
Interventions
- PROCEDURE Control group incision
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2018-03-02 |
| Est. Completion | 2023-01-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04739930
The ClinicalTrials.gov registry entry for NCT04739930 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 429-participant average among 4 other Cartilage Injury trials with a reported enrollment target (92% lower). The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cartilage Injury appearing as the primary indexed condition, and to 1 intervention - of which Control group incision is the first listed.
NCT04739930 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT04739930 about?
NCT04739930 is a clinical study titled "Autologous Bone Marrow Concentrate in Knee Osteochondral Allograft Transplantation". The goal of this study is to establish if mesenchymal stem cell augmentation improves graft incorporation and to analyze the cytokine environment of the joint after osteochondral allograft transplantation (OCA) with and without intra-articular bone marrow aspirate concentrate (BMAC) injection. Infor...
What is the current status of trial NCT04739930?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2018-03-02. Estimated completion is 2023-01-12.
What conditions does trial NCT04739930 study?
This clinical trial studies the following conditions: Cartilage Injury.
What interventions are being tested in trial NCT04739930?
The interventions under investigation include: Control group incision (PROCEDURE).
Who is sponsoring clinical trial NCT04739930?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04739930 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cartilage Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Hyalex Early Feasibility Study (EFS)
RECRUITING · NA
-
Impact of Mesenchymal Stem Cells in Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella
ACTIVE NOT RECRUITING
-
Prospective Registry of Anterior Cruciate Ligament Reconstructions
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.